"Nulief is the next generation holistic medicine that will deliver therapy to those in need," said Mike James, CEO of Inergetics. "We are extremely proud to provide a new alternative without the harmful side effects and addictive attributes of synthetic opiates. The CBD in Nulief can help people who are experiencing discomfort caused by a range of conditions without the 'high' associated with THC found in traditional medicinal marijuana products. Nulief is a nutraceutical that takes Inergetics one step closer to realizing our vision of bringing a suite of farm to formula products to market. We are committed to expanding the Nulief brand into a portfolio of breakthrough supplements that are available in mainstream retail outlets."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.